IntegriChain
Healthcare Software · Pennsylvania, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
100 N 18th St Ste 120, Philadelphia, Pen...Phone Number
(609) 806-5005Website
www.integrichain.comRevenue
$170.6 MillionIndustry
About IntegriChain
IntegriChain is a data and business process platform for therapy commercialization and access. We provide the strategy, data, applications, and business process infrastructure for market access and therapy commercialization. Manufacturers rely on our consulting expertise and ICyte Platform to orchestrate their commercial and government payer contracting, patient services, and distribution channels. ICyte is the first and only platform that unites the financial, operational, and commercial data sets required to support therapy access in the era of specialty and precision medicine. With ICyte, pharmaceutical innovators can digitalize their market access operations, freeing up resources to focus on more data-driven decision supportExplore more
SIC Code 73,737NAICS Code 51,513Show moreIntegriChain Org Chart
Compare Similar Companies to IntegriChain
Compare insights from companies similar to IntegriChain, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$162.2M
501-1,000
Private
$418.9M
2012
RT
Rachel TanDirector, Executive Administration and Strategic Programs, CEO and President
IntegriChain Tech Stack
A closer look at the technologies used by IntegriChain
See more technologies
Top Healthcare Software Companies
Frequently Asked Questions Regarding IntegriChain
Sign Up For FreeTo access detailed company insights
IntegriChain is a data and business process platform for therapy commercialization and access. We provide the strategy, data, applications, and business process infrastructure for market access and therapy commercialization. Manufacturers rely on our consulting expertise and ICyte Platform to orchestrate their commercial and government payer contra... Read More